These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17335183)

  • 1. Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.
    Touaibia M; Djimdé A; Cao F; Boilard E; Bezzine S; Lambeau G; Redeuilh C; Lamouri A; Massicot F; Chau F; Dong CZ; Heymans F
    J Med Chem; 2007 Apr; 50(7):1618-26. PubMed ID: 17335183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
    Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
    Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.
    Dong CZ; Ahamada-Himidi A; Plocki S; Aoun D; Touaibia M; Meddad-Bel Habich N; Huet J; Redeuilh C; Ombetta JE; Godfroid JJ; Massicot F; Heymans F
    Bioorg Med Chem; 2005 Mar; 13(6):1989-2007. PubMed ID: 15727853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.
    Assogba L; Ahamada-Himidi A; Habich NM; Aoun D; Boukli L; Massicot F; Mounier CM; Huet J; Lamouri A; Ombetta JE; Godfroid JJ; Dong CZ; Heymans F
    Eur J Med Chem; 2005 Sep; 40(9):850-61. PubMed ID: 16084626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.
    Guillaume C; Payré C; Jemel I; Jeammet L; Bezzine S; Naika GS; Bollinger J; Grellier P; Gelb MH; Schrével J; Lambeau G; Deregnaucourt C
    Infect Immun; 2015 Jun; 83(6):2453-65. PubMed ID: 25824843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2.
    Mounier CM; Luchetta P; Lecut C; Koduri RS; Faure G; Lambeau G; Valentin E; Singer A; Ghomashchi F; Béguin S; Gelb MH; Bon C
    Eur J Biochem; 2000 Aug; 267(16):4960-9. PubMed ID: 10931177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial Activity of Human Group IIA Secreted Phospholipase A
    Dacheux M; Sinou V; Payré C; Jeammet L; Parzy D; Grellier P; Deregnaucourt C; Lambeau G
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31405958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor.
    Boilard E; Rouault M; Surrel F; Le Calvez C; Bezzine S; Singer A; Gelb MH; Lambeau G
    Biochemistry; 2006 Nov; 45(44):13203-18. PubMed ID: 17073442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of tricyclic dipyrido diazepinone derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
    Thimmegowda NR; Dharmappa KK; Kumar CS; Sadashiva MP; Sathish AD; Nanda BL; Vishwanath BS; Rangappa KS
    Curr Top Med Chem; 2007; 7(8):811-20. PubMed ID: 17456044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
    Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2.
    Cupillard L; Koumanov K; Mattéi MG; Lazdunski M; Lambeau G
    J Biol Chem; 1997 Jun; 272(25):15745-52. PubMed ID: 9188469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.
    Snyder DW; Bach NJ; Dillard RD; Draheim SE; Carlson DG; Fox N; Roehm NW; Armstrong CT; Chang CH; Hartley LW; Johnson LM; Roman CR; Smith AC; Song M; Fleisch JH
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1117-24. PubMed ID: 10027849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
    OmPraba G; Velmurugan D
    Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.
    Boilard E; Bourgoin SG; Bernatchez C; Surette ME
    Blood; 2003 Oct; 102(8):2901-9. PubMed ID: 12829607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
    Teshirogi I; Matsutani S; Shirahase K; Fujii Y; Yoshida T; Tanaka K; Ohtani M
    J Med Chem; 1996 Dec; 39(26):5183-91. PubMed ID: 8978846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
    Oslund RC; Gelb MH
    Biochemistry; 2012 Oct; 51(43):8617-26. PubMed ID: 23020658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors.
    Gopalsamy A; Yang H; Ellingboe JW; McKew JC; Tam S; Joseph-McCarthy D; Zhang W; Shen M; Clark JD
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2978-81. PubMed ID: 16545564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.
    Smart BP; Oslund RC; Walsh LA; Gelb MH
    J Med Chem; 2006 May; 49(10):2858-60. PubMed ID: 16686528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.